Purchase Order 75F40121P00009
- Not listed
- The Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $37,145.96 to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on August 15, 2023, for a QuantStudio 7 Flex real-time polymerase chain reaction (qPCR) system with preventative maintenance and unlimited repairs service agreement. The contract covers a base period with two option years, with an ultimate completion date of August 14, 2026. The contract was awarded without set-aside...
- The U.S. Food and Drug Administration (FDA) awarded a $76,772.10 firm fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for an ABI 7500 Fast Real-Time PCR Instrument. This sole-source award was made under FAR 6.302-1, FAR 13.106(b), and FAR 5.203, as the FDA determined that only Life Technologies could provide the required system. The award does not have a set-aside designation. As a manufacturer of scientific instruments, reagents, and...
- The Food and Drug Administration awarded a $15,682.41 firm fixed-price purchase order to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on July 15, 2019, for a Fast Real Time PCR Systems Service Agreement. The contract, with an ultimate completion date of August 14, 2020, was performed in Carlsbad, California, and involved no set-aside designation. Life Technologies Corporation, a leading manufacturer of scientific instruments and biotechnology products, supplies...
- This federal contract award is for REAL TIME PCR ACCESSORIES valued at $20,923.80. The contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Life Technologies Corporation, doing business as Thermo Fisher Scientific. Life Technologies is a prominent manufacturer of scientific instruments, reagents, and consumables that provides specialized biotechnology products and services to federal agencies. The contract is a firm fixed price purchase order...
- The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $54,160.60 to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on April 1, 2022, for a service and qualification agreement covering a 7500 FAST Real Time PCR System (Serial Number 275015685). The contract, which carries no set-aside designation, specifies performance in Atlanta, Georgia, with an ultimate completion date of March 31, 2027. Life Technologies Corporation, a leading...
- This is a firm fixed-price purchase order awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to provide maintenance services for the ABI 7500 FAST Real-Time PCR System. The $232,357.32 contract was awarded on September 9, 2025, with an ultimate completion date of September 9, 2030. The funding agency is the Food and Drug Administration (FDA), a civilian agency. The contract is not set aside for any specific business type. Life Technologies Corporation is a...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that provides a wide range of products and services to support biomedical research, applied markets, and forensic analysis for the federal government. The contract, valued at $16,708.68, is for a maintenance agreement for a Life Technologies ViiA(TM) real-time PCR system. The contract has an...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is valued at $153,142.00 and runs through June 6, 2027. The contract is for Life Technologies to perform molecular analyses of bacteria isolated from regulatory samples using the ABI7500 Fast Real-Time PCR system. This specialized laboratory equipment is critical for the FDA's Office of Regulatory Affairs...
- This is a $55,293.84 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific. The contract is for preventive maintenance and repair services for three QuantStudio6 PCR systems. The contract was not set aside for a specific business type. As a prominent manufacturer of scientific instruments, reagents, and consumables, Life Technologies has an extensive...
- The Department of Health and Human Services Food and Drug Administration awarded a $918,227.19 firm-fixed-price definitive contract to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the provision of genetic analyzers, warranty, and maintenance services. The contract has an April 26, 2024 completion date and was awarded on April 18, 2019 without the use of a set-aside. Life Technologies Corporation, a leading provider of biomedical research and genetic analysis...
The U.S. Food and Drug Administration (FDA) awarded a $87,843.87 firm-fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, to provide preventative and corrective maintenance services for 7,500 real-time PCR systems over a 4-year period ending on August 31, 2025. This award was not set aside for any small business program. The original solicitation, FDA_21-223-1236746, was posted on November 10, 2020 with a due date of November 20, 2020. As a division of Thermo Fisher Scientific, Life Technologies has delivered genetic analyzers, reagents, assays, and other laboratory equipment and services to support various federal agencies, including the National Institutes of Health, Department of Defense, and Department of Justice. This contract award is likely part of Life Technologies' existing indefinite delivery vehicle contracts with agencies like the NIH, DOI, and VA to provide specialized laboratory equipment and maintenance services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
7500 Fast Real Time PCR Systems Preventative and Corrective Maintenance Service Agreement | FDA_21-223-1236746 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 11/10/20, 5:07 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $19.8k | 6/21/24 | |
| P00004 | Exercise an Option | $18.8k | 3/27/23 | |
| P00003 | Other Administrative Action | $0 | 6/30/22 | |
| P00002 | Exercise an Option | $17.9k | 6/27/22 | |
| P00001 | Exercise an Option | $17.9k | 6/29/21 |